About
Dr. Ryan Nathan Henrie is a Hematologist focused on diagnosing and managing a spectrum of blood disorders, from anemias and clotting issues to blood cancers. Practicing at a specialized cancer centre or hospital department in New Westminster, BC, he is part of a dedicated healthcare team committed to providing comprehensive blood disorder treatment. His approach emphasizes patient-centered care, ensuring that each individual receives personalized and hopeful management of their condition. The practice adheres to the standards and guidelines set by the College of Physicians and Surgeons of British Columbia (CPSBC), reflecting a commitment to excellence and safety in medical practice.
He graduated with a Medical Degree from the University of Manitoba in 2018 and completed extensive postgraduate training in Hematology (Blood Disorders). Dr. Henrie holds certifications including those from the Royal College of Physicians and Surgeons of Canada, demonstrating his expertise and dedication to ongoing professional development. His education and training enable him to offer advanced diagnostic and therapeutic options for a wide range of hematologic conditions.
Dr. Henrie’s clinical philosophy centers on multidisciplinary care, evidence-based treatment, and supporting patients and their families through complex medical journeys. He is dedicated to advancing research in hematology and providing hope through innovative therapies. Fluent in English, he is committed to clear communication and compassionate care for adults with suspected or diagnosed blood disorders and cancers in the New Westminster community.
Dr. Ryan Henrie has expertise in managing a wide range of conditions, including:
Hematologic Malignancies (Blood Cancers) Treated
- Chronic Myeloid Leukemia (CML): A type of cancer that starts in certain blood-forming cells of the bone marrow, often managed with targeted therapies.
- Hodgkin Lymphoma: A cancer of the lymphatic system, part of the immune system, characterized by the presence of Reed-Sternberg cells.
- Multiple Myeloma: A cancer of plasma cells, a type of white blood cell in the bone marrow that produces antibodies, leading to bone damage and other complications.
Benign Hematologic (Non-Cancerous Blood) Disorders Managed
- Aplastic Anemia & Bone Marrow Failure Syndromes: Rare but serious conditions where the bone marrow doesn't produce enough new blood cells.
- Von Willebrand Disease & Other Inherited Bleeding Disorders: Genetic conditions that impair the blood's ability to clot effectively, causing prolonged or excessive bleeding.
- Thrombophilia & Acquired Clotting Disorders (e.g., DVT/PE management, Antiphospholipid Syndrome): Conditions that increase the tendency to form blood clots, requiring anticoagulation therapy and management.
This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Ryan Henrie or your referring physician.
- Second Opinion Consultations for Cancer & Blood Disorders: Providing expert second opinions on complex diagnoses and proposed treatment plans to ensure informed decision-making.
- Bone Marrow Aspiration & Biopsy (Performance or Interpretation): Performing or interpreting samples from bone marrow aspirations and biopsies to diagnose blood disorders and cancers.
- Comprehensive Oncologic & Hematologic Consultation: In-depth evaluation of medical history, review of diagnostic imaging and pathology, cancer staging (if applicable), and development of personalized treatment plans for various cancers and blood disorders.
- Diagnosis & Management of Multiple Myeloma, Waldenström's Macroglobulinemia & Other Plasma Cell Dyscrasias: Specialized care for cancers arising from plasma cells, utilizing novel agents, chemotherapy, and supportive care, including stem cell transplant coordination.
- Management of Myelodysplastic Syndromes (MDS): Diagnosis and treatment of bone marrow failure disorders, including supportive care, growth factors, and disease-modifying therapies.
- Autologous & Allogeneic Stem Cell Transplant Consultation, Coordination & Post-Transplant Care (as part of a transplant team or referral network): Evaluating eligibility for, coordinating referrals to, and providing follow-up care for patients undergoing stem cell transplantation for hematologic malignancies.
- Iron Overload Disorders (e.g., Hereditary Hemochromatosis) Management: Monitoring and treatment, including therapeutic phlebotomy, for conditions of excess iron storage.
Note: This list provides a general overview of services offered in Hematology (Blood Disorders). Treatment plans are highly individualized. Dr. Henrie provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Henrie or your healthcare team for details relevant to your care.
All medical services and treatments are provided in accordance with the standards of practice set by the College of Physicians and Surgeons of British Columbia (CPSBC) and relevant cancer care guidelines. A referral is required.
Dr. Henrie practices at a specialized cancer centre located in the Uptown, Massey Victory Heights neighborhood of New Westminster, BC. The facility is situated near the Royal City Centre Mall, making it convenient for patients. It is accessible via public transit, including the TransLink (SkyTrain Expo Line) and local bus services. The centre is wheelchair accessible, ensuring ease of access for all patients. Metered street parking is available nearby, providing additional convenience for visitors. The practice is dedicated to providing comprehensive blood disorder diagnosis and treatment services in a welcoming and accessible environment.
- Are consultations and treatments with Dr. Henrie, an Hematologist, covered by Medical Services Plan (MSP) in BC?
- Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Hematologist such as Dr. Henrie are generally covered by Medical Services Plan (MSP) in BC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Medical Services Plan (MSP), Dr. Henrie's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.
- Do I need a referral to see Dr. Henrie, an Hematologist?
- Yes, a referral from your family physician or another specialist is almost always required to see an Hematologist like Dr. Henrie for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.
- What is palliative care, and when might Dr. Henrie discuss it?
- Palliative care is specialized medical care focused on providing relief from the symptoms and stress of a serious illness, like cancer or advanced blood disorders. The goal is to improve quality of life for both the patient and the family. It can be provided at any stage of illness, alongside curative treatments, not just at the end of life. Dr. Henrie may discuss palliative care if you are experiencing significant symptoms, to help manage pain, fatigue, nausea, anxiety, or other issues, and to provide an extra layer of support.
- How does cancer or blood disorder treatment differ for children compared to adults?
- As a Pediatric Hematologist/Oncologist, Dr. Henrie specializes in these differences. Children's bodies react differently to treatments, and the types of cancers and blood disorders are often distinct from adult conditions. Treatment protocols are specifically designed for pediatric patients, considering their growth and development. Care is family-centered, involving parents and caregivers closely in decision-making and support.
- Does Dr. Henrie participate in or offer access to clinical trials?
- You can ask Dr. Henrie if there are any suitable clinical trials available for your condition, either at Dr. Henrie's institution or through collaborative research networks. He can provide information or refer you for consideration.
- How will treatment decisions be made for my condition by Dr. Henrie?
- Treatment decisions in oncology and hematology are highly personalized and made collaboratively. Dr. Henrie will consider many factors, including the type and stage of your cancer or blood disorder, your overall health, genetic markers of the disease (if applicable), current treatment guidelines, and importantly, your personal preferences and values. Often, cases are discussed in multidisciplinary team meetings (tumor boards) with other specialists to ensure a comprehensive approach. You will be an active participant in this decision-making process.
330 Columbia St E, Royal Columbian Hospital
New Westminster, BC V3L 3W7
Phone: (604) 777-8358 | Fax: (604) 520-4778
The facility is wheelchair accessible.
Dr. Henrie is a licensed Hematologist regulated by the College of Physicians and Surgeons of British Columbia (CPSBC) under the Health Professions Act in BC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.
Verify registration with the College of Physicians and Surgeons of British Columbia (CPSBC): https://www.cpsbc.ca/public/registrant-directory/search-result/363547/Henrie%2CRyan
